Overview

* Else Nutrition Q3 gross margin rises to 34% from negative 9% in Q3 2024

* Operating expenses decreased 68% yr/yr, totaling C$1.15 mln in Q3 2025

* Revenue stable at C$1.66 mln, slightly down from $1.79 mln in Q3 2024

Outlook

* Else Nutrition expects continued operational improvements in Q4

* Company is preparing for next clinical phase of plant-based infant formula

* Else Nutrition focuses on resolving supply chain challenges and expanding presence

Result Drivers

* GROSS MARGIN EXPANSION - Co attributes surge in gross margin to successful cost optimization and manufacturing transition

* COST REDUCTION - Operating expenses decreased by 68% yr/yr due to disciplined cost management

* REVENUE STABILITY - Revenue remained stable at C$1.66 mln, slightly down from C$1.79 mln in Q3 2024 due to temporary out-of-stock issues

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 C$1.66

Revenue mln

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)